Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hashim

Showing results (471-480 of 482) with videos related to

Pageof 49
Sort By:
Plants (Basel, Switzerland)|December 28, 2021
Foliar Application of Nano, Chelated, and Conventional Iron Forms Enhanced Growth, Nutritional Status, Fruiting Aspects, and Fruit Quality of Washington Navel Orange Trees (<i>Citrus sinensis</i> L. <i>Osbeck</i>)Sherif F El-Gioushy, Zheli Ding, Asmaa M E Bahloul, et al.
Therapeutic Advances in Gastroenterology|November 2, 2020
Ustekinumab dose escalation improves clinical responses in refractory Crohn's diseaseSyedreza A Haider, Abhijeet Yadav, Courtney Perry, et al.
Diabetes|July 2, 1999
A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty ratK K Brown, B R Henke, S G Blanchard, et al.
Journal of Medicinal Chemistry|December 4, 1998
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agentsB R Henke, S G Blanchard, M F Brackeen, et al.
Journal of Medicinal Chemistry|May 30, 2003
Neuromuscular blocking activity and therapeutic potential of mixed-tetrahydroisoquinolinium halofumarates and halosuccinates in rhesus monkeysEric E Boros, Vicente Samano, John A Ray, et al.
Journal of Viral Hepatitis|June 3, 2022
International multicenter validation of GES score for HCC risk stratification in chronic hepatitis C patientsGamal Shiha, Reham Soliman, Nabiel N H Mikhail, et al.
Heliyon|July 31, 2024
Factors affecting mortality in COVID-19-associated pulmonary aspergillosis: An international ID-IRI studyMeyha Sahin, Mesut Yilmaz, Ali Mert, et al.
Progress in Cardiovascular Diseases|May 13, 2023
Biomarkers for the Diagnosis of Heart Failure in People with Diabetes: A Consensus Report from Diabetes Technology SocietyAndrea M Yeung, Jingtong Huang, Ambarish Pandey, et al.
The Review of Scientific Instruments|January 1, 2022
Axion Dark Matter Experiment: Detailed design and operationsR Khatiwada, D Bowring, A S Chou, et al.
Journal of Viral Hepatitis|October 30, 2015
Strategies to manage hepatitis C virus infection disease burden - volume 3F Z Alfaleh, N Nugrahini, M Matičič, et al.
Pageof 49

Showing results (471-480 of 482) with videos related to

Sort By:
Pageof 49
Plants (Basel, Switzerland)|December 28, 2021
Foliar Application of Nano, Chelated, and Conventional Iron Forms Enhanced Growth, Nutritional Status, Fruiting Aspects, and Fruit Quality of Washington Navel Orange Trees (<i>Citrus sinensis</i> L. <i>Osbeck</i>)Sherif F El-Gioushy, Zheli Ding, Asmaa M E Bahloul, et al.
Therapeutic Advances in Gastroenterology|November 2, 2020
Ustekinumab dose escalation improves clinical responses in refractory Crohn's diseaseSyedreza A Haider, Abhijeet Yadav, Courtney Perry, et al.
Diabetes|July 2, 1999
A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty ratK K Brown, B R Henke, S G Blanchard, et al.
Journal of Medicinal Chemistry|December 4, 1998
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agentsB R Henke, S G Blanchard, M F Brackeen, et al.
Journal of Medicinal Chemistry|May 30, 2003
Neuromuscular blocking activity and therapeutic potential of mixed-tetrahydroisoquinolinium halofumarates and halosuccinates in rhesus monkeysEric E Boros, Vicente Samano, John A Ray, et al.
Journal of Viral Hepatitis|June 3, 2022
International multicenter validation of GES score for HCC risk stratification in chronic hepatitis C patientsGamal Shiha, Reham Soliman, Nabiel N H Mikhail, et al.
Heliyon|July 31, 2024
Factors affecting mortality in COVID-19-associated pulmonary aspergillosis: An international ID-IRI studyMeyha Sahin, Mesut Yilmaz, Ali Mert, et al.
Progress in Cardiovascular Diseases|May 13, 2023
Biomarkers for the Diagnosis of Heart Failure in People with Diabetes: A Consensus Report from Diabetes Technology SocietyAndrea M Yeung, Jingtong Huang, Ambarish Pandey, et al.
The Review of Scientific Instruments|January 1, 2022
Axion Dark Matter Experiment: Detailed design and operationsR Khatiwada, D Bowring, A S Chou, et al.
Journal of Viral Hepatitis|October 30, 2015
Strategies to manage hepatitis C virus infection disease burden - volume 3F Z Alfaleh, N Nugrahini, M Matičič, et al.
Pageof 49